Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
Basophil responsiveness in chronic urticaria
Current Allergy and Asthma Reports, 08/06/09
Saini SS – In active chronic idiopathic urticaria (CIU) subjects, changes in IgE receptor–signaling molecule expression levels accompany the altered degranulation function in blood basophils. The arrival of therapies targeting IgE has further shown that altered blood basophil degranulation behavior has potential use as a disease biomarker in CIU.
Related Articles
The definition and diagnostic testing of physical and cholinergic urticarias - EAACI/GA2LEN/EDF/UNEV consensus panel recommendations
Allergy, 11/16/09
Relevance Score: 88%
Solar urticaria
Allergy and Asthma Proceedings, 10/12/09
Relevance Score: 88%
Outpatient urticaria diagnosis codes have limited predictive value for same-day influenza vaccine adverse event detection
Journal of Clinical Epidemiology, 11/09/09
Relevance Score: 87%
Results and relevance of critical temperature threshold testing in patients with acquired cold urticaria
British Journal of Dermatology, 10/05/09
Relevance Score: 87%
Usefulness of the CD63 basophil activation test in detecting Anisakis hypersensitivity in patients with chronic urticaria: diagnosis and follow-up
Clinical and Experimental Dermatology, 11/02/09
Relevance Score: 84%
Today in Derm Allergy/Immunology...keeping you current
Receive free subspecialty "5-minute updates" via email
Molecular diagnostics of psoriasis, atopic dermatitis, allergic contact dermatitis and irritant contact dermatitis
British Journal of Dermatology, 12/04/09
Homoeopathic versus Conventional Therapy for Atopic Eczema in Children: Medical and Economic Results
Dermatology, 12/04/09
Interferon-gamma (INF-gamma) release test can detect cutaneous adverse effects to statins
International Journal of Dermatology, 12/04/09
Sponsor
Article Search
Sponsor


See Latest Articles


